Fourth quarter trading update

NZX & ASX RELEASE Ryman Healthcare reports 331 sales of retirement living occupation right agreements (ORAs) for the quarter ending 31 March 2026 (Q4 FY26), including 81 new sales and 250 resales. Total sales were up 10% on Q4 FY25, and down on the prior quarter due to lower internal transfers. Ryman delivered total sales of 1,410 ORAs in FY26, including 348 new sales and 1,062 resales. Reported sales volumes include 39 retirement living resident relocations from Margaret Stoddart and Woodcote villages as their care centres progressively closed during the year. Excluding these relocations, total sales were 1,371, in line with Ryman’s market guidance of 1,300–1,400 provided at its half year results. CEO Naomi James said, “We’re pleased with our final quarter trading results and encouraged by sustained improvement across lead indicators, including net sales applications exceeding turnover levels for the first time since we made changes to our contract terms in late 2024. Our new DMF of 30% is now widely accepted, and we continue to see evidence our targeted sales and marketing strategies are working, with growth in move-ins from external customers on these terms.” New sales of independent units eased versus recent quarters as expected, given fewer new unit completions coming to market, while new sales of serviced apartments were robust, with Kevin Hickman, Keith Park and Bert Newton villages being key contributors. Ryman completed stages at Keith Park in February, bringing total FY26 development completions to 330 units and beds, in-line with market guidance. Total resales volumes were below the prior quarter due to lower internal transfers. External resales volumes increased on the prior quarter, with robust volumes achieved across both independent living units and serviced apartments throughout many locations. Demand for Ryman’s care offering remains strong across its approximately 4,700 aged care beds, reflecting growing demand. Mature care centre occupancy was sustained at 96.1% in Q4, consistent with 96.0% in Q3. Developing care centres continue to fill ahead of expectations, with four of the five opened in the past two years now above 80% occupancy at 31 March 2026. The recent conflict in the Middle East and the associated economic effects have not had an impact on settled sales or Ryman’s broader business to date. However, the company is closely monitoring potential flow-on impacts to cost inflation, interest rates and residential real estate markets. Ryman remains focused on disciplined capital management and maintaining prudent gearing levels. As previously communicated, Ryman’s active development programme continues to moderate, with only two sites under active construction at year end, significantly reducing exposure to construction cost inflation. Ryman’s free cash flow for FY26 is expected to be approximately $180 million, driven by strong cash flow performance in the second half. Ryman’s net interest-bearing debt at 31 March 2026 was $1.57 billion, with over three quarters of drawn debt on fixed interest rates. This information is unaudited and subject to completion of the year-end financial reporting process. Ryman will report its FY26 results on 26 May 2026. Please see accompanying release for webcast details. Authorised by Morgan Powell General Counsel About Ryman Founded in Christchurch in 1984, Ryman Healthcare is New Zealand’s largest retirement living and aged care provider, and the leading integrated retirement living and aged care operator in Victoria. Dual listed on the NZX and ASX, Ryman owns and operates 49 integrated retirement villages across New Zealand and Australia, providing homes to over 15,000 residents and employing 7,800 dedicated team members. Ryman’s villages provide a fully integrated continuum of care, bringing together independent living, assisted living, and aged care services within a single community. This model offers residents choice, continuity, and a genuine home for life experience as their needs change, while giving families confidence and peace of mind. Committed to high standards of quality and service, Ryman delivers exceptional living and care experiences alongside long-term value for residents, families, and shareholders. Contacts For investor relations information Hayden Strickett, Head of Investor Relations hayden.strickett@rymanhealthcare.com For media information Sarah Greig, GM Corporate Affairs & Communication sarah.greig@rymanhealthcare.com